Visfatin Level in Diabetic and Non-diabetic Chronic Kidney Diseases

Journal Title: Asian Journal of Medicine and Health - Year 2017, Vol 6, Issue 1

Abstract

Introduction: Chronic kidney disease (CKD) has become a global public health threat. The irreversible nature of the disease, its association with significant morbidity and mortality as well as the cost of renal replacement therapy leads to a large burden for health care providers, particularly in developing countries like Egypt. Objective: To find a non-invasive method to evaluate association of serum visfatin with chronic kidney disease secondary to diabetic nephropathy and compare to patients with chronic kidney disease secondary to other causes. Methods: Ninety individuals including 30 healthy controls and 60 patients of CKD were included in this study. Patients with CKD were further grouped based on etiology of CKD into 30 diabetic patients and 30 non-diabetic patients. Patients with type 1 diabetes mellitus, urinary tract infection, urolithiasis, liver cirrhosis, stroke, ischemic heart disease, and rheumatoid arthritis were excluded. Measurement of serum visfatin was done through ELISA Kit (Elabscience pharmaceuticals). Results: Visfatin concentration was significantly high in patients with CKD compared to controls (p < 0 .001). No significant difference in Visfatin concentrations between patients of CKD with and without diabetes was detected (p > 0.05). Visfatin concentration was significantly high in patients with CKD stage 2 compared to CKD stage 1 (p < 0 .001). Conclusion: The present study confirms the association of visfatin with CKD, however further studies at molecular level to check its expression within renal tissue may clarify its definitive role in CKD.

Authors and Affiliations

Samer S. Zekry, Maher A. Al Amir, Mohamed A. Mashahit, Hoiyda A. Abd El-Rasol, Ehab A. Hassan

Keywords

Related Articles

Gangrenous Gut in a Pregnant woman: A Case Report

Gangrene of the intestines is a rare complication in pregnancy. Intestinal obstruction and ischemic bowel diseases are common causes of gangrene of the intestines in pregnancy. Adhesion bands can cause intestinal obstruc...

Sickle Cell Anaemia: A Prevalence Study among the Children Attending Usmanu Danfodiyo University Teaching Hospital, Sokoto, North-Western Nigeria

Aims: The aim of this study was to determine prevalence of Sickle Cell Anaemia (SCA) and other abnormal haemoglobin variants among the children attending the Paediatrics outpatients Department of Usmanu Danfodiyo Univers...

A Questionnaire Study of Food – Drug Interactions to Assess Knowledge of People from Diverse Backgrounds

Background: Food drug interactions contribute a major reason for drug interactions but they are neglected due to less knowledge and awareness on it. Objective: To assess the awareness about food drug interactions among v...

Determinants of Low Infant Birth Weight in the Tamale Metropolis, Ghana

Aim: This study was conducted to assess the determinants of low infant birth weight in the Tamale metropolis of Ghana. Study Design: Descriptive cross-sectional study. Place and Duration of Study: Postnatal and child wel...

Development or Adaptation of Clinical Guidelines in the Health System of Developing Countries: A Review Article

Clinical guideline is one of the best approaches to improve clinical care. The content of this study is part of a database review which has been developed by reviewing and studying the world’s most renowned organizations...

Download PDF file
  • EP ID EP336732
  • DOI 10.9734/AJMAH/2017/36085
  • Views 76
  • Downloads 0

How To Cite

Samer S. Zekry, Maher A. Al Amir, Mohamed A. Mashahit, Hoiyda A. Abd El-Rasol, Ehab A. Hassan (2017). Visfatin Level in Diabetic and Non-diabetic Chronic Kidney Diseases. Asian Journal of Medicine and Health, 6(1), 1-11. https://europub.co.uk/articles/-A-336732